“Arab syndrome” hampers Armenian company’s export

“Arab syndrome” hampers Armenian company’s export

PanARMENIAN.Net - CEO of ARPIMED LLC Vachagan Ghazaryan said that 15% growth was recorded in the company’s production in Q1 2011 compared to the same period in 2010

The company expects to record increase both in internal market’s consumption and export (30%) in Q2 2011.

“The paces of growth are maintained in the company; they would have been higher, if it were not for the events in the Arab states, with which we established cooperation,” Ghazaryan told a press conference in Yerevan.

8 Armenian companies, including ARPIMED LLC, were awarded by a medal of Armenian Prime Minister Tigran Sargsyan for contribution to the country’s economy.

ARPIMED LLC invested USD 1.5mln in 2010, due to which the company will produce 30 new medicines in 2011. “Currently, they undergo the procedure of registration, after which they will be exported to Ukraine, Belarus and Georgia,” said Ghazaryan.

ARPIMED LLC is the only pharmaceutical company, which has the French GMP standard that facilitates the company’s export to European countries.

Ghazaryan also reported that over half of the company’s output (147 different products) is exported.

 Top stories
Yerevan has dismissed Turkey’s demand to shut down the Armenian nuclear power plant as “inappropriate”.
Armenia will loan 2.9 billion drams to Nagorno Karabakh (Artsakh), according to a draft government decision.
The Ministry of Ecology and Natural Resources of Azerbaijan has “strongly condemned” Armenia’s decision.
Kerobyan has said that for the first time in the history of Armenia, the volume of foreign direct investments amounted to about $1 billion.
Partner news
---